Report Detail
Global Panitumumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3748140 |
- 14 September, 2019 |
- Global |
- 100 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
Scope of the Report:
The global Panitumumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Panitumumab.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Panitumumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Panitumumab market by product type and applications/end industries.
Market Segment by Companies, this report covers
Amgen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Market Segment by Applications, can be divided into
Hospital
Drug store
Table of Contents
1 Panitumumab Market Overview
- 1.1 Product Overview and Scope of Panitumumab
- 1.2 Classification of Panitumumab by Types
- 1.2.1 Global Panitumumab Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Panitumumab Revenue Market Share by Types in 2018
- 1.2.3 100 mg/5 mL single-dose vials
- 1.2.4 400 mg/20 mLsingle-dose vials
- 1.3 Global Panitumumab Market by Application
- 1.3.1 Global Panitumumab Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Global Panitumumab Market by Regions
- 1.4.1 Global Panitumumab Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Panitumumab Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Panitumumab Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Panitumumab Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Panitumumab Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Panitumumab Status and Prospect (2014-2024)
- 1.5 Global Market Size of Panitumumab (2014-2024)
2 Manufacturers Profiles
- 2.1 Amgen
- 2.1.1 Business Overview
- 2.1.2 Panitumumab Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Amgen Panitumumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Panitumumab Market Competition, by Players
- 3.1 Global Panitumumab Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Panitumumab Players Market Share
- 3.2.2 Top 10 Panitumumab Players Market Share
- 3.3 Market Competition Trend
4 Global Panitumumab Market Size by Regions
- 4.1 Global Panitumumab Revenue and Market Share by Regions
- 4.2 North America Panitumumab Revenue and Growth Rate (2014-2019)
- 4.3 Europe Panitumumab Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Panitumumab Revenue and Growth Rate (2014-2019)
- 4.5 South America Panitumumab Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Panitumumab Revenue and Growth Rate (2014-2019)
5 North America Panitumumab Revenue by Countries
- 5.1 North America Panitumumab Revenue by Countries (2014-2019)
- 5.2 USA Panitumumab Revenue and Growth Rate (2014-2019)
- 5.3 Canada Panitumumab Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Panitumumab Revenue and Growth Rate (2014-2019)
6 Europe Panitumumab Revenue by Countries
- 6.1 Europe Panitumumab Revenue by Countries (2014-2019)
- 6.2 Germany Panitumumab Revenue and Growth Rate (2014-2019)
- 6.3 UK Panitumumab Revenue and Growth Rate (2014-2019)
- 6.4 France Panitumumab Revenue and Growth Rate (2014-2019)
- 6.5 Russia Panitumumab Revenue and Growth Rate (2014-2019)
- 6.6 Italy Panitumumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Panitumumab Revenue by Countries
- 7.1 Asia-Pacific Panitumumab Revenue by Countries (2014-2019)
- 7.2 China Panitumumab Revenue and Growth Rate (2014-2019)
- 7.3 Japan Panitumumab Revenue and Growth Rate (2014-2019)
- 7.4 Korea Panitumumab Revenue and Growth Rate (2014-2019)
- 7.5 India Panitumumab Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Panitumumab Revenue and Growth Rate (2014-2019)
8 South America Panitumumab Revenue by Countries
- 8.1 South America Panitumumab Revenue by Countries (2014-2019)
- 8.2 Brazil Panitumumab Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Panitumumab Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Panitumumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Panitumumab by Countries
- 9.1 Middle East and Africa Panitumumab Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Panitumumab Revenue and Growth Rate (2014-2019)
- 9.3 UAE Panitumumab Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Panitumumab Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Panitumumab Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Panitumumab Revenue and Growth Rate (2014-2019)
10 Global Panitumumab Market Segment by Type
- 10.1 Global Panitumumab Revenue and Market Share by Type (2014-2019)
- 10.2 Global Panitumumab Market Forecast by Type (2019-2024)
- 10.3 100 mg/5 mL single-dose vials Revenue Growth Rate (2014-2024)
- 10.4 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2014-2024)
11 Global Panitumumab Market Segment by Application
- 11.1 Global Panitumumab Revenue Market Share by Application (2014-2019)
- 11.2 Panitumumab Market Forecast by Application (2019-2024)
- 11.3 Hospital Revenue Growth (2014-2019)
- 11.4 Drug store Revenue Growth (2014-2019)
12 Global Panitumumab Market Size Forecast (2019-2024)
- 12.1 Global Panitumumab Market Size Forecast (2019-2024)
- 12.2 Global Panitumumab Market Forecast by Regions (2019-2024)
- 12.3 North America Panitumumab Revenue Market Forecast (2019-2024)
- 12.4 Europe Panitumumab Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Panitumumab Revenue Market Forecast (2019-2024)
- 12.6 South America Panitumumab Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Panitumumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Panitumumab. Industry analysis & Market Report on Panitumumab is a syndicated market report, published as Global Panitumumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Panitumumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
